Literature DB >> 86390

New natural products of interest under development at the National Cancer Institute.

J Douros, M Suffness.   

Abstract

Fourteen new agents of natural products origin which are under development as antitumor agents at the National Cancer Institute are discussed with reference to their sources, structures, antitumor activity, current status, and future prospects as clinically effective agents.

Mesh:

Substances:

Year:  1978        PMID: 86390     DOI: 10.1007/BF00254042

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  16 in total

1.  Baccharin, a novel potent antileukemic trichothecene triepoxide from Baccharis megapotamica.

Authors:  S M Kupchan; B B Jarvis; R J Dailey; W Bright; R F Bryan; Y Shizuri
Journal:  J Am Chem Soc       Date:  1976-10-27       Impact factor: 15.419

Review 2.  Antineoplastic agents from plants.

Authors:  M E Wall; M C Wani
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  U-42, 126, a new antimetabolite antibiotic: production, biological activity, and taxonomy of the producing microorganism.

Authors:  L J Hanka; A Dietz
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

4.  Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica.

Authors:  S M Kupchan; R W Britton; M F Ziegler; C W Sigel
Journal:  J Org Chem       Date:  1973-01-12       Impact factor: 4.354

5.  Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus.

Authors:  S M Kupchan; Y Komoda; W A Court; G J Thomas; R M Smith; A Karim; C J Gilmore; R C Haltiwanger; R F Bryan
Journal:  J Am Chem Soc       Date:  1972-02-23       Impact factor: 15.419

6.  The structures of toxins from two strains of Fusarium tricinctum.

Authors:  J R Bamburg; N V Riggs; F M Strong
Journal:  Tetrahedron       Date:  1968-04       Impact factor: 2.457

7.  Structures of harringtonine, isoharringtonine, and homoharringtonine.

Authors:  R G Powell; D Weisleder; C R Smith; W K Rohwedder
Journal:  Tetrahedron Lett       Date:  1970-03       Impact factor: 2.415

Review 8.  Novel plant-derived tumor inhibitors and their mechanisms of action.

Authors:  S M Kupchan
Journal:  Cancer Treat Rep       Date:  1976-08

9.  Structural requirements for biological activity among antileukemic glaucarubolone ester quassinoids.

Authors:  S M Kupchan; J A Lacadie; G A Howie; B R Sickles
Journal:  J Med Chem       Date:  1976-09       Impact factor: 7.446

Review 10.  Types of anticancer agents isolated from plants.

Authors:  J L Hartwell
Journal:  Cancer Treat Rep       Date:  1976-08
View more
  9 in total

1.  p53-independent apoptosis induced by paclitaxel through an indirect mechanism.

Authors:  J S Lanni; S W Lowe; E J Licitra; J O Liu; T Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Current trends in the chemoprevention of cancer.

Authors:  Fazlul H Sarkar
Journal:  Pharm Res       Date:  2010-04-17       Impact factor: 4.200

3.  Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

Authors:  Jin-Hui Yuan; Ru-Ping Zhang; Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Dan Luo; Yong Xie; Hong Xie
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

4.  The cytotoxicity of T-2 toxin and related 12,13-epoxytrichothecenes to Adriamycin-sensitive and -resistant P388 leukemia cells.

Authors:  A Ramu; B Yagen; N Ramu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Disposition and metabolism of bruceantin in the mouse.

Authors:  W J Suling; C W Woolley; W M Shannon
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Clinical pharmacology of bruceantin by radioimmunoassay.

Authors:  K L Fong; D H Ho; R S Benjamin; N S Brown; A Bedikian; B S Yap; C L Wiseman; W Kramer; G P Bodey
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Inhibition of glutathione synthesis augments lysis of murine tumor cells by sulfhydryl-reactive antineoplastics.

Authors:  B A Arrick; C F Nathan; Z A Cohn
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

8.  Therapeutic response to taxol of six human tumors xenografted into nude mice.

Authors:  J Riondel; M Jacrot; F Picot; H Beriel; C Mouriquand; P Potier
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Evaluation of Antioxidant and Wound Healing Effects of Alcoholic and Aqueous Extract of Ocimum sanctum Linn in Rats.

Authors:  Somashekar Shetty; Saraswati Udupa; Laxminarayana Udupa
Journal:  Evid Based Complement Alternat Med       Date:  2008-03       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.